Tao Zhang, Qian Zhang, Dai-xiong Chen, Jia-Ye Jiang, Qixin Zhou
{"title":"罗格列酮通过激活PPARγ抑制人乳腺癌细胞株MDA-MB-231的生长","authors":"Tao Zhang, Qian Zhang, Dai-xiong Chen, Jia-Ye Jiang, Qixin Zhou","doi":"10.1007/S11805-008-0407-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39865,"journal":{"name":"中国肿瘤临床","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/S11805-008-0407-6","citationCount":"6","resultStr":"{\"title\":\"Growth inhibiton of human breast cancer cell line MDA-MB-231 by rosiglitazone through activation of PPARγ\",\"authors\":\"Tao Zhang, Qian Zhang, Dai-xiong Chen, Jia-Ye Jiang, Qixin Zhou\",\"doi\":\"10.1007/S11805-008-0407-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":39865,\"journal\":{\"name\":\"中国肿瘤临床\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-12-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/S11805-008-0407-6\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国肿瘤临床\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/S11805-008-0407-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国肿瘤临床","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/S11805-008-0407-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
期刊介绍:
CHINESE JOURNAL OF CLINICAL ONCOLOGY has become a good teacher and companion for guiding the workers of medical oncology, with high creativity, science, practice and readability. Relying on the Chinese edition of CJCO and with first class international publication as its object, the staff of the English edition editorial office fully exert their own predominance, and highlight the principle and characteristics of the journal. Under the guidance and support of senior oncologists and their many colleagues, the English edition of CJCO will, we hope, provide a way for the English speaking would to learn about Chinese research in the field of Oncology.